Expert Speaks of Innovative Work in Breast Cancer Research

By Tosin Clegg

Nigerian scientist and oncological researcher, Olanike Olowokere, is advancing global breast cancer research through innovative investigations into early tumor progression and metastasis.

Speaking in a media statement recently, she emphasized that understanding the earliest interactions between cancer cells and surrounding tissues is essential to preventing metastasis, strengthening early detection systems, and developing more precise targeted therapies.

Olowokere’s research focuses on the critical role of the stromal microenvironment in breast cancer development, highlighting how subtle cellular exchanges determine whether a tumor remains contained or becomes aggressive.

She explains in the statement, “When the body senses injury, fibroblasts and immune cells coordinate signals that repair tissue. But in cancer, these same signals can become hijacked. Understanding the earliest miscommunications between cells and the stromal microenvironment can help us intervene before metastasis begins.”

Her work explores how disruptions in these cell conversations escalate an early lesion into a life-threatening disease, offering deeper clarity on the early stages of tumor evolution.

One of Olowokere’s most notable contributions is the development of a novel molecular tracer that allows scientists to visualize in real time how tumor-derived signals influence normal cells.

This innovative work enables researchers to track how breast cancer cells “prime” distant organs, such as the lungs and brain, long before metastases become physically detectable.

She noted in her statement that this innovation has already gained international attention, especially among scientists studying the premetastatic niche, a frontier area in cancer biology aimed at identifying the earliest steps in cancer spread.

Her findings reinforce growing scientific evidence that early disturbances in cell-to-cell communication can predict the behavior of breast cancer and guide the development of more precise, targeted treatments.

Olowokere’s scientific journey began in Nigeria where she studied environmental toxicity and neuroprotection as an undergraduate.

She later completed a research-intensive master’s degree at Covenant University and strengthened her expertise in cancer genomics while working in a molecular biology laboratory.

These experiences laid the foundation for her doctoral research at the University of Utah’s Huntsman Cancer Institute where she now investigates how subtle cellular interactions shape clinical outcomes.

Beyond her laboratory work, Olowokere is an active advocate for strengthening scientific capacity across Africa. She mentors young scientists, supports training initiatives, and emphasizes the importance of investing in research infrastructure.

“Africa is full of brilliant minds,” she said. “If we strengthen our research systems and create more opportunities for young scientists, we can generate discoveries that benefit global health.”

Olowokere’s contributions to understanding tumor microenvironments and early metastatic conditioning offer promising pathways for improved diagnostics and therapies, bringing the world closer to halting aggressive breast cancer before it spreads.